Todos Medical Announces Tollovid® Products Exclusive License & Distribution Agreement with T-Cell Protect Hellas S.A. Covering 30 Countries in Europe
November 18, 2021 06:00 ET
|
Todos Medical Ltd.
The Agreement Calls for a Minimum of 500,000 Bottles in Sales Over 18 Months T-Cell Protect to Invest 1 Million Euros in Todos to Support Development of Tollovir, the Company’s 3CL Protease...